Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting its diverse portfolio of orthopedic and musculoskeletal innovations at the ...

Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...

President and Chief Executive Officer at Zimmer Biomet. "We are in the midst of one of the largest innovation cycles in our company's history. Our broad hip reconstruction portfolio combined with ...

Assetmark Inc. decreased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 67.7% in the 4th quarter, ...

Zimmer Biomet, one of the largest orthopaedic medtech companies in the world, has launched a campaign with Hollywood actor ...

We came across a bullish thesis on Zimmer Biomet Holdings, Inc. (ZBH) on Twitter by QuestforYield. In this article, we will ...

Hans Zimmer is an unlikely rock star ... The line to enter wrapped all around the Nets’ home arena. Thousands of hip twenty and thirty-somethings with a love for cinematic scores — I ...

Zimmer Biomet ZBH continues to gain from procedure strength, strong execution and solid momentum in innovation. Yet the stock ...

Orthopedic surgery is a marvelous field because we can make meaningful improvements in the comfort and function of patients ...

Zimmer Biomet (NYSE: ZBH) announced that Ivan Tornos will become chair of its board following the retirement of Christopher Begley.

Zimmer Biomet is suffering due to macroeconomic uncertainties, pricing pressure and unfavorable currency fluctuations.